Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Salivary Gland Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 22Cisplatin 17Surveys and Questionnaires 9Radiotherapy 8Carboplatin 8Radiotherapy, Intensity-Modulated 7Cetuximab 7Paclitaxel 6Nivolumab 6Drug Therapy 6Radiation 4Fluorouracil 4Taxes 3Docetaxel 3selpercatinib 2dostarlimab 2Yoga 2Surgical Procedures, Operative 2Standard of Care 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Chemoradiotherapy 2Blood Specimen Collection 2ALX148 2veliparib 1tisotumab vedotin 1tislelizumab 1palbociclib 1osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Head and Neck Neoplasms × EBC-46 × Clear all
NCT05608876 2025-08-07

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

QBiotics Group Limited

Phase 2 Active not recruiting
15 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡